162 related articles for article (PubMed ID: 9818678)
1. Roles of COX-1 and COX-2.
McCormack K
J Rheumatol; 1998 Nov; 25(11):2279-81. PubMed ID: 9818678
[No Abstract] [Full Text] [Related]
2. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
3. [Selective cyclooxygenase-2 (COX-2) inhibitors. Beliefs, reality and hope].
Brune K
Orthopade; 1997 Sep; 26(9):804-6; discussion 807. PubMed ID: 9432666
[No Abstract] [Full Text] [Related]
4. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
5. The role of cyclooxygenase-2 in the pathogenesis of skin cancer.
Brecher AR
J Drugs Dermatol; 2002 Jul; 1(1):44-7. PubMed ID: 12847753
[TBL] [Abstract][Full Text] [Related]
6. [Cyclooxygenase-2 (COX-2) in digestive cancer. Therapeutic implications].
Bessa X; Piñol V; Elizalde JI; Castells A
Gastroenterol Hepatol; 2000 Dec; 23(10):483-90. PubMed ID: 11149225
[No Abstract] [Full Text] [Related]
7. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
8. [Current topics in the regulation of prostanoids-1. Inducible cyclooxygenase COX-2 and selective blockers].
Ohara M; Sawa T
Masui; 1998 Nov; 47(11):1325-32. PubMed ID: 9852696
[TBL] [Abstract][Full Text] [Related]
9. The disputed role of COX-2 in myocardial infarction, is the jury still out?
Patel HH; Gross GJ
J Mol Cell Cardiol; 2002 Jan; 34(1):1-3. PubMed ID: 11812159
[No Abstract] [Full Text] [Related]
10. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
11. [COX-2].
Oh-ishi S
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1109-13. PubMed ID: 10771681
[No Abstract] [Full Text] [Related]
12. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
Dammann HG
Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
[TBL] [Abstract][Full Text] [Related]
13. [Significance of COX-2].
Tatsuguchi A; Sakamoto C
Nihon Rinsho; 2002 Feb; 60 Suppl 2():207-10. PubMed ID: 11979779
[No Abstract] [Full Text] [Related]
14. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
15. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
16. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
17. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
18. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
19. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]